Educational
2025 Look Ahead
Is it “too late” to enter digital assets?
by Fidelity Digital Assets®
January 7, 2025 • 60 min read
Digital assets experienced two significant waves of acceleration in the first half of 2024 with the approval of the exchange traded products (ETPs) followed by a post-election surge at the end of 2024. Now, following the industry’s historic year, many investors are asking themselves, “Am I too late?”
Our 2025 Look Ahead explores the answer to that question, analyzing how new developments may intersect with the macroeconomic environment and what it all could imply for institutional portfolios. Each member of our Research team shares an analysis of the trends they are closely following, with featured topics including:
- Predictions for the long-term adoption of digital assets
- An analysis of Ethereum Layer 2s and coming upgrades
- Bitcoin’s changing landscape and growing scaling opportunities
- Expanded and evolving use cases for stablecoins
Access the full report now for exclusive insights into these developments and more to help inform investment strategies in the year ahead.
The information herein was prepared by Fidelity Digital Asset Services, LLC (“FDAS LLC”) and Fidelity Digital Assets, Ltd (“FDA LTD”), and Fidelity Digital Assets Ireland Limited ("FDA Ireland"). It is for informational purposes only and is not intended to constitute a recommendation, investment advice of any kind, or an offer to buy or sell any asset. Perform your own research and consult a qualified advisor to see if digital assets are an appropriate investment option.
Digital assets are speculative and highly volatile, can become illiquid at any time, and are for investors with a high-risk tolerance. Investors in digital assets could lose the entire value of their investment.
Custody and trading of digital assets are provided by Fidelity Digital Asset Services, LLC, which is chartered as a limited purpose trust company by the New York State Department of Financial Services to engage in virtual currency business (NMLS ID 1773897) ("FDAS LLC"). FDA LTD and FDA Ireland rely on FDAS LLC for these services. FDA LTD is registered with the Financial Conduct Authority under the U.K.’s Money Laundering Regulations. The Financial Ombudsman Service and the Financial Services Compensation Scheme do not apply to the cryptoasset activities carried on by FDA LTD. FDA Ireland is incorporated in Ireland as a private limited company and provides certain virtual asset services described in the Criminal Justice (Money Laundering and Terrorist Financing) Acts 2010 to 2021. FDA Ireland is registered with the Central Bank of Ireland for anti-money laundering and countering the financing of terrorism (AML/CFT) purposes only (C526991).
To the extent this communication constitutes a financial promotion in the U.K., it is issued only to, or directed only at, persons who are: (i) investment professionals within the meaning of Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO"); (ii) high net worth companies and certain other entities falling within Article 49 of the FPO; and (iii) any other persons to whom it may lawfully be communicated.
This information is not intended for distribution to, or use by, anyone in any jurisdiction where such distribution would be contrary to local law or regulation. Persons accessing this information are required to inform themselves about and observe such restrictions.
FDAS LLC, FDA LTD, and FDA Ireland do not provide tax, legal, investment, or accounting advice. This material is not intended to provide, and should not be relied on, for tax, legal, or accounting advice. Tax laws and regulations are complex and subject to change. You should consult your own tax, legal, and accounting advisors before engaging in any transaction.
Fidelity Digital Assets is a registered service mark, and the Fidelity Digital Assets logo is a service mark of FMR LLC.
© 2025 FMR LLC. All rights reserved